[LXRX] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
03-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 11.75%
YoY- -0.81%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 218 372 199 300 343 355 555 -46.21%
PBT -24,873 -29,539 -25,459 -29,387 -33,845 -26,103 -25,896 -2.63%
Tax -55,799 -576 -643 485 -56,267 560 712 -
NP -24,873 -29,539 -25,931 -29,868 -33,845 -26,103 -26,638 -4.44%
Tax Rate - - - - - - - -
Total Cost 25,091 29,911 26,130 30,168 34,188 26,458 27,193 -5.19%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -11,409.63 -7,940.59 -13,030.65 -9,956.00 -9,867.35 -7,352.96 -4,799.64 77.65%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS -0.34 -0.42 -0.38 -0.44 -0.49 -0.54 -0.55 -27.32%
EPS Diluted -0.34 -0.42 -0.38 -0.44 -0.49 -0.54 -0.55 -27.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.